| B1931036 | A PROSPECTIVE, RANDOMIZED, OPEN-LABEL PHASE 2 STUDY TO EVALUATE THE SUPERIORITY OF INOTUZUMAB OZOGAMICIN MONOTHERAPY VER | active | ALL | Lymphatisches und blutbildendes System |
| Baseline characterization of immune checkpoints | Baseline characterization of immune checkpoints in unresectable hepatocellular carcinoma patients – Cohort trial | active | Hepatozelluläres Karzinom (HCC) | Leber; Gallenblase und Gallenwege |
| BCA101X301 | A Multicenter, Randomized, Double-blind, Phase 2/3 Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pemb | active | Plattenepithelkarzinom | Kopf-Hals |
| BELLA | A Phase 2 Study of Relacorilant in Combination with Nab-paclitaxel and Bevacizumab in Advanced, Epithelial Ovarian, Prim | active | Ovarialkarzinom | Weibliche Genitalorgane |
| BI 1479-0009 | BI1479-0009 | active | Adenokarzinom | Organübergreifend |
| BiliCan | Biliary liquid biopsies for early cancer diagnosis in patients with indeterminate biliary strictures (BiliCan) | active | Karzinom | Leber; Gallenblase und Gallenwege |
| BioBankHaut | Klinisches Register und Biobanking in der Dermatologie | active | Malignes Melanom | Haut |
| Biomaterialsammlung von Patienten mit Kopf-Hals-Tumor | Biomaterialsammlung von Patienten mit Kopf-Hals-Tumor zur wissenschaftlichen Untersuchung | active | Karzinom | Organübergreifend |
| BMBC (GBG 79) | Brain Metastases in Breast Cancer Network Germany | active | Karzinom | Brust |
| BMS CA224-0012 | BMS CA244-0012 | active | Karzinom | Harnorgane |
| BNGO Protokoll13902 | "Real-world Analyse von Patienten-, Krankheits- und Therapiemerkmalen in Verbindung mit der Entscheidungsfindung un | active | Mammakarzinom | Brust |
| BNT326-01 | BNT326-01 | active | Karzinom | Organübergreifend |
| BNT327-03 | A Phase III, multisite, double-blinded randomized trial of BNT327 in combination with chemotherapy (etoposide/carboplati | active | Neuroendokrin (NET and NEC) | Lunge und Bronchien |
| Brain-RF | Amplitude modulated radiofrequency electromagnetic field treatment combined with radiochemotherapy and maintenance chemo | active | Hirntumor | ZNS |
| BrigaPed | A Phase I/II study of Brigatinib in pediatric and young adult patients with ALK+ Anaplastic Large Cell Lymphoma, Inflamm | active | Sonstiges | Sonstiges |
| BYP Register (Berlin Young Patients) | Register für Brustkrebs vor dem 40. Lebensjahr - Um die Besonderheiten von Brustkrebs und Brustkrebsvorstufen (DCIS) jun | active | Karzinom | Brust |
| C4221026 (FLOTILLA) | Master Protocol for Encorafenib/Binimetinib Continuation Sub-Studies (FLOTILLA Study) | active | Karzinom | Organübergreifend |
| C5751003 | An Open-Label, Randomized, Controlled Phase 3 Study Of Sigvotatug Vedotin In Combination With Pembrolizumab Compared Wit | active | NSCLC | Lunge und Bronchien |
| C6461003 Pfizer | AN INTERVENTIONAL, PHASE 3, DOUBLE-BLIND, RANDOMIZED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-08634404 IN COMBINA | active | Adenokarzinom | Unterer GI-Trakt |
| CA082-1215 (CAROLYN) | The CAROLYN Trial: Lisocabtagene Maraleucel as First-Line Therapy for Primary Central Nervous System Lymphoma (PCNSL) in | active | ZNS-Lymphom | ZNS |
| CA209-649 | A Randomized, Multicenter, Open-Label, Phase 3 Study of Nivolumab plus Ipilimumab orNivolumab in Combination with Oxalip | active | gastric-gastroesophageal junction (GEJ) cancer | Oberer GI-Trakt |
| CA224-1093 | A Phase 3, Randomized, Open-label Study of Nivolumab + Relatlimab Fixed-dose Combination With Chemotherapy Versus Pembro | active | NSCLC | Lunge und Bronchien |
| CA266-0004 ROSETTA | A Blinded, Randomized, Phase 2/3 Study of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination Wit | active | Adenokarzinom | Oberer GI-Trakt |
| CABL001A2001B | An open label, multi-center asciminib roll-over study to assess long-term safety in patients who have completed a Novart | active | Sonstiges | Sonstiges |
| CANDOID (BC/CRC) | Establishment of representative 3D model systems of metastatic colon and breast cancer for rapid pharmacotyping (CANDOID | active | Adenokarzinom, Karzinom | Organübergreifend |
| Canfour CAN04 | An open label, dose escalation followed by dose expansion, safety and tolerability trial of CAN04, a fully humanized mon | active | Karzinom | Organübergreifend |
| CAR-T solide Tumoren | Mononukleäre Zellen zur Immuntherapie: Verwendung mononukleärer Zellen zur Generierung von Chimären Antigen Rezeptor (CA | active | Karzinom | Organübergreifend |
| CAR-T-Fitness | Identifizierung spezifischer Expressionsmarker als Vorhersage für eine erfolgreiche Expansion von T-Zellen für die adapt | active | Sonstiges | Sonstiges |
| Cardia | Surgery for adenocarcinoma of the gastroesophageal junction (GEJ) type II: Transthoracic esophagectomy vs. transhiatal e | active | Adenokarzinom | Oberer GI-Trakt |
CATCH (mBC) NCT-Studie | Comprehensive Assessment of clinical feaTures and biomarkers to identify patients with advanced or metastatic breast Can | active | Karzinom | Brust |
| CATCH/ COGNITIONNCT-Studie | Comprehensive assessment of clinical features, genomics and further molecular markers to identify patients with early br | active | Mammakarzinom | Brust |
| CD45RADLIHaplo | A multi-center phase I/II trial of memory T cell donor lymphocyte infusions after transplantation of CliniMACS TCRα/β an | active | AML, MDS, Neuroblastom | Lymphatisches und blutbildendes System |
| CELESTIAL | Clinical Experience with Letermovir for CMV-Prophylaxis in Hemato-oncological Patients (CELESTIAL) | active | Leukämien/Lymphome | Lymphatisches und blutbildendes System |
| Cellestia | Cellestia CB 103-C-101 | active | Karzinom | Organübergreifend |
| CIC424C2301 | A Phase III Randomized Open-label Multi-center Study of Ruxolitinib Versus Best Available Therapy in Patients With Corti | active | Karzinom | Organübergreifend |
| CIEMAR | CIRSE Emprint Microwave Ablation Registry | active | Karzinom | Organübergreifend |
| CL3-95031-007 | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled Study of Ivosidenib in Participants =18 Years of Ag | active | Chondrosarkom | Organübergreifend |
| CLIN-60000-467 (CaboLife) | A Prospective Non-Interventional Study on Effectiveness and Safety of Cabozantinib in Real-Life Setting for Previously T | active | Sonstiges | Sonstiges |
| CLL16-Studie | Eine prospektive, offene, multizentrische, randomisierte Phase-3-Studie mit Acalabrutinib, Obinutuzumab und Venetoclax ( | active | CLL | Lymphatisches und blutbildendes System |
| CLL18 (MOIRAI) | Eine multizentrische, randomisierte, prospektive, offene Phase-III-Studie zum Vergleich von zeitlich begrenzter Therapie | active | Sonstiges | Sonstiges |
| CNS-InterREST GPOH | Internationales Register für seltene Embryonale und Sarkomatöse Tumoren des ZNS | active | Karzinom | ZNS |
| CO46096 (CEVOLUTION) | A Phase III, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Cevostamab in Combination W | active | Sonstiges | Sonstiges |
| CodeBreaK 301 | Phase 3 Multicenter, Randomized, Open-label, Active-controlled Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIR | active | Sonstiges | Sonstiges |
| COGNITION-GUIDENCT-Studie | COGNITION-GUIDE - Genomics guided targeted post-neoadjuvant therapy in patients with early breast cancer. A multicenter, | active | Mammakarzinom | Brust |
| COMFORT | COMputational Models FOR patienT stratification in urologic cancers – Creating robust and trustworthy multimodal AI for | active | Karzinom | Organübergreifend |
| COMPASS | Comparison of Quality of life (QoL) between trabectedin/PLD and standard platinum-based therapy in patients with platinu | active | Ovarialkarzinom | Weibliche Genitalorgane |
| CONNECT | Verbunden in Isolation – Entwicklung und Machbarkeitsstudie einer digitalen Gruppenintervention zum Umgang mit Belastung | active | Leukämien/Lymphome | Lymphatisches und blutbildendes System |
| CoReCC3 IIT | First in Human Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of the Bispecific CD276xCD3 | active | Karzinom | Organübergreifend |
| COSS-Register | COSS-Register: Clinical Registry for children, adolescents and adults with Osteosarcoma and Bone Tumors | active | Sonstiges | Sonstiges |
| CPT-SIOP-Register | CPT-SIOP-Register (Choroid-Plexus-Tumore) | active | Sonstiges | Sonstiges |
Klinische Studien – Charité Comprehensive Cancer Center